Medifast Inc (MED) 37.61 $MED
Medifast, Inc. Announces Quarterly Dividend
PR Newswire - Thu Sep 08, 4:00PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has approved the declaration of a $0.25 cash dividend to its stockholders. The quarterly cash dividend of $0.25 per share is payable on November 10, 2016 to stockholders of record as of the close of business on September 23, 2016.
MED: 37.61 (+0.59)
Medifast, Inc. Announces Second Quarter 2016 Financial Results
PR Newswire - Wed Aug 03, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the second quarter ended June 30, 2016.
MED: 37.61 (+0.59)
Food Stocks Earnings Lined Up for Aug 3: MED, MGPI & OME
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:18AM CDT
Three food stocks are scheduled to release their second-quarter numbers on Aug 3.
MDLZ: 42.87 (-0.04), OME: 24.45 (-0.32), BGS: 47.39 (-0.15), HSY: 95.45 (-0.03), MED: 37.61 (+0.59), PF: 50.51 (+0.29), MGPI: 40.02 (-0.17), CL: 72.19 (+0.23)
Medifast, Inc. to Participate in the 17th Annual B. Riley & Co. Investor Conference
PR Newswire - Wed May 11, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that Timothy Robinson, Chief Financial Officer, will present at the 17th Annual B. Riley & Co. Investor Conference on Wednesday, May 25, 2016 in Hollywood, CA.
MED: 37.61 (+0.59)
5 DuPont-Tested Stocks that Promise Solid Returns
Zacks Equity Research - Zacks Investment Research - Fri May 06, 12:42PM CDT
Taking a step beyond the basic ROE and analyzing it at an advanced level could lead to better returns.
PM: 98.82 (-0.02), TJX: 74.69 (+0.02), MED: 37.61 (+0.59), NVR: 1,658.08 (+1.08)
Medifast posts 1Q profit
Automated Insights - Wed May 04, 4:39PM CDT
OWINGS MILLS, Md. (AP) _ Medifast Inc. (MED) on Wednesday reported first-quarter profit of $4.3 million.
MED: 37.61 (+0.59)
Medifast, Inc. Announces First Quarter 2016 Financial Results
PR Newswire - Wed May 04, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the first quarter ended March 31, 2016.
MED: 37.61 (+0.59)
McCormick Buys Botanical Food Company for $114M Cash
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 10:42AM CDT
McCormick & Co., Inc. (MKC) recently announced the acquisition of Australia-based Botanical Food Company, Pty Ltd, a privately held firm, for approximately 150 million Australian dollars ($114 million) in cash.
MKC: 96.38 (+0.52), MED: 37.61 (+0.59), SYY: 49.25 (-0.13), CPB: 55.31 (-0.07)
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2016
PR Newswire - Thu Apr 14, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, will announce financial results for the first quarter ended March 31, 2016 on Wednesday, May 4, 2016, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Michael C. MacDonald, Chairman and Chief Executive Officer, and Timothy Robinson, Chief Financial Officer.
MED: 37.61 (+0.59)
McCormick Withdraws Bid for Premier Foods; Shares Fall
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:50PM CDT
McCormick & Co., Inc. (MKC) recently announced that it has abandoned its plans to acquire UK-based Premier Foods, after completing its due diligence review of the food manufacturer. Shares of McCormick declined 2.2% on Apr 13.
MKC: 96.38 (+0.52), MED: 37.61 (+0.59), SYY: 49.25 (-0.13), CPB: 55.31 (-0.07)
Moving Average Crossover Alert: Medifast (MED)
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 8:24AM CDT
Medifast Inc. (MED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
MED: 37.61 (+0.59)
Medifast® Announces Latest Industry and Community Recognitions for Chairman & Chief Executive Officer Michael MacDonald
PR Newswire - Tue Feb 02, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is proud to announce that its Chairman & CEO Michael MacDonald was appointed to serve as Treasurer of the Direct Selling Association (DSA), a national trade association of the leading firms that manufacture and distribute goods and services sold directly to consumers. A member of the DSA executive committee since 2014, MacDonald is also an active board member of the Direct Selling Education Foundation (DSEF), which offers consumer, education, ethics, and entrepreneurship initiatives that help demonstrate direct selling's important role in supporting communities and strengthening economies.
MED: 37.61 (+0.59)
Nutrisystem (NTRI) Adds 16 Items to Menu, Unveils New Diet
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 10:50AM CST
Nutrisystem Inc. (NTRI) has added 16 new items to its ready-to-go and fresh-frozen line of products.
MED: 37.61 (+0.59), NTRI: 28.30 (+0.76), WMT: 72.09 (-0.78), WTW: 9.89 (+0.11)
Medifast® Introduces Sports Nutrition Product Line, Partners with The V Foundation for Cancer Research® and Rutgers University® to Launch Dual Fuel(TM)
PR Newswire - Wed Jan 20, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today the launch of a sports nutrition product line, which will be marketed through partnerships with Rutgers University® and The V Foundation for Cancer Research®. The V Foundation, one of the nation's leading cancer research funding organizations, was started by famed college basketball coach and revered Rutgers' Alum, Jim Valvano.
MED: 37.61 (+0.59)
Upgrade Alert for Medifast (MED)
Comtex SmarTrend(R) - Tue Jan 12, 8:04AM CST
Medifast (NYSE:MED) was upgraded from Neutral to Buy at Sidoti today. The stock closed yesterday at $29.40 on volume of 179,000 shares, above average daily volume of 106,000. Over the past year, Medifast has traded in a range of $26.14 to $33.86 and closed yesterday at $29.40, 12% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.
MED: 37.61 (+0.59)
Take Shape For Life® Kicks-Off New Year with Success Stories Featured in People Magazine's Annual Half Their Size Issue
PR Newswire - Mon Jan 11, 7:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is excited to announce that three weight loss successes in their Take Shape For Life direct selling division have been featured in the January 11, 2016 People Magazine's Half Their Size issue, available on newsstands now. This year, Take Shape For Life successes Heather Patterson (43), and husband and wife team, Steven (57) and Susan Smelser (55), shared their inspirational stories and credited their weight-loss transformations to Take Shape For Life. In the issue, they highlighted the organization's proven products and programs, their Health Coaches, and community of support which fosters Optimal Health.
MED: 37.61 (+0.59)
Medifast® Declares 2016 "Your Year" in New Ad Campaign
PR Newswire - Thu Jan 07, 6:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today announced plans for a new national advertising campaign entitled "Your Year." Backed by customer insights, the campaign introduces new television and digital assets that allow people to see what their own weight loss success might look like, rather than just hearing about the success of others. This fresh approach for 2016 demonstrates Medifast's continued growth and ingenuity leading into 2016.
MED: 37.61 (+0.59)
Medifast, Inc. to Participate in the 18th Annual ICR Conference
PR Newswire - Mon Jan 04, 3:05PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that Meg Sheetz, President and Chief Operating Officer, and Timothy Robinson, Chief Financial Officer, will present at the 18th Annual ICR Conference on Wednesday, January 13, 2016 in Orlando, FL.
MED: 37.61 (+0.59)
Medifast, Inc. Announces Initiation of Quarterly Dividend
PR Newswire - Wed Dec 16, 3:15PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has authorized a dividend program under which it intends to pay a regular quarterly cash dividend to its stockholders. The initial quarterly cash dividend of $0.25 per share is payable on February 10, 2016 to stockholders of record as of the close of business on December 28, 2015.
MED: 37.61 (+0.59)
Medifast, Inc. Announces Quarterly Dividend
PR Newswire - Thu Sep 08, 4:00PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has approved the declaration of a $0.25 cash dividend to its stockholders. The quarterly cash dividend of $0.25 per share is payable on November 10, 2016 to stockholders of record as of the close of business on September 23, 2016.
MED: 37.61 (+0.59)
Medifast, Inc. Announces Second Quarter 2016 Financial Results
PR Newswire - Wed Aug 03, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the second quarter ended June 30, 2016.
MED: 37.61 (+0.59)
Food Stocks Earnings Lined Up for Aug 3: MED, MGPI & OME
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:18AM CDT
Three food stocks are scheduled to release their second-quarter numbers on Aug 3.
MDLZ: 42.87 (-0.04), OME: 24.45 (-0.32), BGS: 47.39 (-0.15), HSY: 95.45 (-0.03), MED: 37.61 (+0.59), PF: 50.51 (+0.29), MGPI: 40.02 (-0.17), CL: 72.19 (+0.23)
Medifast, Inc. to Participate in the 17th Annual B. Riley & Co. Investor Conference
PR Newswire - Wed May 11, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that Timothy Robinson, Chief Financial Officer, will present at the 17th Annual B. Riley & Co. Investor Conference on Wednesday, May 25, 2016 in Hollywood, CA.
MED: 37.61 (+0.59)
5 DuPont-Tested Stocks that Promise Solid Returns
Zacks Equity Research - Zacks Investment Research - Fri May 06, 12:42PM CDT
Taking a step beyond the basic ROE and analyzing it at an advanced level could lead to better returns.
PM: 98.82 (-0.02), TJX: 74.69 (+0.02), MED: 37.61 (+0.59), NVR: 1,658.08 (+1.08)
Medifast posts 1Q profit
Automated Insights - Wed May 04, 4:39PM CDT
OWINGS MILLS, Md. (AP) _ Medifast Inc. (MED) on Wednesday reported first-quarter profit of $4.3 million.
MED: 37.61 (+0.59)
Medifast, Inc. Announces First Quarter 2016 Financial Results
PR Newswire - Wed May 04, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the first quarter ended March 31, 2016.
MED: 37.61 (+0.59)
McCormick Buys Botanical Food Company for $114M Cash
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 10:42AM CDT
McCormick & Co., Inc. (MKC) recently announced the acquisition of Australia-based Botanical Food Company, Pty Ltd, a privately held firm, for approximately 150 million Australian dollars ($114 million) in cash.
MKC: 96.38 (+0.52), MED: 37.61 (+0.59), SYY: 49.25 (-0.13), CPB: 55.31 (-0.07)
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2016
PR Newswire - Thu Apr 14, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, will announce financial results for the first quarter ended March 31, 2016 on Wednesday, May 4, 2016, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Michael C. MacDonald, Chairman and Chief Executive Officer, and Timothy Robinson, Chief Financial Officer.
MED: 37.61 (+0.59)
McCormick Withdraws Bid for Premier Foods; Shares Fall
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:50PM CDT
McCormick & Co., Inc. (MKC) recently announced that it has abandoned its plans to acquire UK-based Premier Foods, after completing its due diligence review of the food manufacturer. Shares of McCormick declined 2.2% on Apr 13.
MKC: 96.38 (+0.52), MED: 37.61 (+0.59), SYY: 49.25 (-0.13), CPB: 55.31 (-0.07)
Moving Average Crossover Alert: Medifast (MED)
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 8:24AM CDT
Medifast Inc. (MED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
MED: 37.61 (+0.59)
Medifast® Announces Latest Industry and Community Recognitions for Chairman & Chief Executive Officer Michael MacDonald
PR Newswire - Tue Feb 02, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is proud to announce that its Chairman & CEO Michael MacDonald was appointed to serve as Treasurer of the Direct Selling Association (DSA), a national trade association of the leading firms that manufacture and distribute goods and services sold directly to consumers. A member of the DSA executive committee since 2014, MacDonald is also an active board member of the Direct Selling Education Foundation (DSEF), which offers consumer, education, ethics, and entrepreneurship initiatives that help demonstrate direct selling's important role in supporting communities and strengthening economies.
MED: 37.61 (+0.59)
Nutrisystem (NTRI) Adds 16 Items to Menu, Unveils New Diet
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 10:50AM CST
Nutrisystem Inc. (NTRI) has added 16 new items to its ready-to-go and fresh-frozen line of products.
MED: 37.61 (+0.59), NTRI: 28.30 (+0.76), WMT: 72.09 (-0.78), WTW: 9.89 (+0.11)
Medifast® Introduces Sports Nutrition Product Line, Partners with The V Foundation for Cancer Research® and Rutgers University® to Launch Dual Fuel(TM)
PR Newswire - Wed Jan 20, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today the launch of a sports nutrition product line, which will be marketed through partnerships with Rutgers University® and The V Foundation for Cancer Research®. The V Foundation, one of the nation's leading cancer research funding organizations, was started by famed college basketball coach and revered Rutgers' Alum, Jim Valvano.
MED: 37.61 (+0.59)
Upgrade Alert for Medifast (MED)
Comtex SmarTrend(R) - Tue Jan 12, 8:04AM CST
Medifast (NYSE:MED) was upgraded from Neutral to Buy at Sidoti today. The stock closed yesterday at $29.40 on volume of 179,000 shares, above average daily volume of 106,000. Over the past year, Medifast has traded in a range of $26.14 to $33.86 and closed yesterday at $29.40, 12% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.
MED: 37.61 (+0.59)
Take Shape For Life® Kicks-Off New Year with Success Stories Featured in People Magazine's Annual Half Their Size Issue
PR Newswire - Mon Jan 11, 7:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is excited to announce that three weight loss successes in their Take Shape For Life direct selling division have been featured in the January 11, 2016 People Magazine's Half Their Size issue, available on newsstands now. This year, Take Shape For Life successes Heather Patterson (43), and husband and wife team, Steven (57) and Susan Smelser (55), shared their inspirational stories and credited their weight-loss transformations to Take Shape For Life. In the issue, they highlighted the organization's proven products and programs, their Health Coaches, and community of support which fosters Optimal Health.
MED: 37.61 (+0.59)
Medifast® Declares 2016 "Your Year" in New Ad Campaign
PR Newswire - Thu Jan 07, 6:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today announced plans for a new national advertising campaign entitled "Your Year." Backed by customer insights, the campaign introduces new television and digital assets that allow people to see what their own weight loss success might look like, rather than just hearing about the success of others. This fresh approach for 2016 demonstrates Medifast's continued growth and ingenuity leading into 2016.
MED: 37.61 (+0.59)
Medifast, Inc. to Participate in the 18th Annual ICR Conference
PR Newswire - Mon Jan 04, 3:05PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that Meg Sheetz, President and Chief Operating Officer, and Timothy Robinson, Chief Financial Officer, will present at the 18th Annual ICR Conference on Wednesday, January 13, 2016 in Orlando, FL.
MED: 37.61 (+0.59)
Medifast, Inc. Announces Initiation of Quarterly Dividend
PR Newswire - Wed Dec 16, 3:15PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has authorized a dividend program under which it intends to pay a regular quarterly cash dividend to its stockholders. The initial quarterly cash dividend of $0.25 per share is payable on February 10, 2016 to stockholders of record as of the close of business on December 28, 2015.
MED: 37.61 (+0.59)
